Upregulation of Fas and FasL in taiwan cobra phospholipase A 2-treated human neuroblastoma SK-N-SH cells through ROS- And Ca 2+-mediated p38 MAPK activation

Journal of Cellular Biochemistry

Volumn 106, Issue 1, 2009, Pages 93-102

  Chen, Ku Chung ^a   Kao, Pei Hsiu ^a   Lin, Shinne Ren ^a   Chang, Long Sen ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Ca2+; Fas FasL upregulation; P38 mapk activation; Phospholipase A2; ROS

Indexed keywords

ACETYLCYSTEINE; ARACHIDONIC ACID; CALCIUM ION; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; FAS ANTIGEN; FAS LIGAND; LYSOPHOSPHATIDYLCHOLINE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PHOSPHOLIPASE A2;

ANTIGEN EXPRESSION; ARTICLE; CALCIUM CELL LEVEL; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; NERVE CELL NECROSIS; NEUROBLASTOMA CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SNAKE; TAIWAN;

ANIMALS; ANTIGENS, CD95; ARACHIDONIC ACID; CALCIUM; CELL LINE, TUMOR; COBRA VENOMS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FAS LIGAND PROTEIN; HUMANS; NEUROBLASTOMA; NEURONS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOLIPASES A2; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SIGNAL TRANSDUCTION; UP-REGULATION;

NAJA ATRA;

EID: 58649106021     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21979     Document Type: Article

References (31)

1. 2 for cerebellar granule neurons. FEBS Lett 579:2693-2701.
2. 2+-activated NADPH oxidase in testis, spleen and lymph nodes. J Biol Chem 276:37594-37601.
3. Beer R, Franz G, Schopf M, Reindl M, Zelger B, Schmutzhard E, Poewe W, Kampfl A. 2000. Expression of Fas and Fas ligand after experimental traumatic brain injury in the rat. J Cereb Blood Flow Metab 20:669-677.
4. Biedler JL, Roffler-Tarlov S, Schachner M, Freedman LS. 1978. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res 33:2643-2652.
5. Camins A, Pallas M, Silvestre JS. 2008. Apoptotic mechanisms involved in neurodegenerative diseases: Experimental and therapeutic approaches. Methods Find Exp Clin Pharmacol 30:43-65.
6. 2. J Biochem (Tokyo) 124:764-768.
7. 2 on human neuroblastoma SK-N-SH cells. Toxicol Lett 180:53-58.
8. 2 potentiates glutamate-induced calcium increase and cell death in primary neuronal cultures. J Neurosci Res 67:634-645.
9. 2: A perspective on the history. Prostaglandins Leukot Essent Fatty Acids 71:161-169.
10. Ferrer I, Blanco R, Cutillas B, Ambrosio S. 2000. Fas and Fas-L expression in Huntington's disease and Parkinson's disease. Neuropathol Appl Neurobiol 26:424-433.
11. Ferrer I, Puig B, Krupinsk J, Carmona M, Blanco R. 2001. Fas and Fas ligand expression in Alzheimer's disease. Acta Neuropathol 102:121-131.
12. 2 in the human astrocytoma cell line 1321N1. J Biol Chem 273:606-612.
13. 2. J Pept Sci 14:342-348.
14. 2 enzymes: Structure, function and mechanism. Chichester: John Wiley & Sons. pp 1-28.
15. 2-mediated neuronal cell death involves glutamate ionotropic receptors. Neuroreport 13:1963-1966.
16. 2 enzymes: Structure, function and mechanism. Chichester: John Wiley & Sons. pp 389-412.
17. Li GL, Farooque M, Olsson Y. 2000. Changes of Fas and Fas ligand immu-noreactivity after compression trauma to rat spinal cord. Acta Neuropathol 100:75-81.
18. 2 in reactive astrocytes in response to transient focal cerebral ischemia in the rat brain. J Neurochem 90:637-645.
19. 2-IIA and ROS generation in peripheral mitochondria are critical for neuronal death. Brain Res 1153:43-51.
20. 2-IIA: A new inflammatory factor for Alzheimer's disease. J Neuroinflammation 3:28.
21. Olney JW. 2002. New insights and new issues in developmental neurotox-icology. Neurotoxicology 23:659-668.
22. 2 modulate the release of arachidonic acid from neuronal membranes. J Neurosci Res 68:558-567.
23. Siegmund D, Klose S, Zhou D, Baumann B, Roder C, Kalthoff H, Wajant H, Trauzold A. 2007. Role of caspases in CD95L- and TRAIL-induced non-apoptotic signalling in pancreatic tumour cells. Cell Signal 19:1172-1184.
24. 2 in central nervous system: Implications for neurodegenerative diseases. J Lipid Res 45:205-213.
25. 2 in oxidative and inflammatory responses in neurodegenerative diseases. J Neurochem 103:1-16.
26. Thorburn A. 2004. Death receptor-induced cell killing. Cell Signal 16:139-144.
27. Villena J, Henriquez M, Torres V, Moraga F, Diaz-Elizondo J, Arredondo C, ChiongM, Olea-Azar C, Stutzin A, Lavandero S, Quest AFG. 2008. Ceramide- induced formation of ROS and ATP depletion trigger necrosis in lymphoid cells. Free Radic Biol Med 44:1146-1160.
28. Yagami T, Ueda K, Asakura K, Hayasaki-Kajiwara Y, Nakazato T, Sakaeda T, Hata S, Kuroda K, Takasu N, Hori Y. 2002a. Group IB secretory phospholipase A induces neuronal cell death via apoptosis. J Neurochem 81:449-461.
29. Yagami T, Ueda K, Asakura K, Hata S, Kuroda T, Sakaeda T, Takasu N, Tanaka K, Gemba T, Hori Y. 2002b. Human group IIA secretory phospholipase A induces neuronal cell death via apoptosis. Mol Pharmacol 61:114-126.
30. 2+ channels. Brain Res 960:71-80.
31. 2+ channel. J Neurochem 85:749-758.